Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

Patra K, Soosaipillai A, Sando SB, Lauridsen C, Berge G, Møller I, Grøntvedt GR, Bråthen G, Begcevic I, Moussaud S, Minthon L, Hansson O, Diamandis EP, White LR, Nielsen HM.

Alzheimers Res Ther. 2018 Jan 29;10(1):9. doi: 10.1186/s13195-018-0336-4.

2.

Low levels of very-long-chain n-3 PUFA in Atlantic salmon (Salmo salar) diet reduce fish robustness under challenging conditions in sea cages.

Bou M, Berge GM, Baeverfjord G, Sigholt T, Østbye TK, Ruyter B.

J Nutr Sci. 2017 Jun 28;6:e32. doi: 10.1017/jns.2017.28. eCollection 2017.

3.

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.

Lauridsen C, Sando SB, Møller I, Berge G, Pomary PK, Grøntvedt GR, Salvesen Ø, Bråthen G, White LR.

Front Aging Neurosci. 2017 Jun 28;9:210. doi: 10.3389/fnagi.2017.00210. eCollection 2017.

4.

Effects of dietary n-3 fatty acids on Toll-like receptor activation in primary leucocytes from Atlantic salmon (Salmo salar).

Arnemo M, Kavaliauskis A, Andresen AMS, Bou M, Berge GM, Ruyter B, Gjøen T.

Fish Physiol Biochem. 2017 Aug;43(4):1065-1080. doi: 10.1007/s10695-017-0353-4. Epub 2017 Mar 9.

PMID:
28280951
5.

EPA, DHA, and Lipoic Acid Differentially Modulate the n-3 Fatty Acid Biosynthetic Pathway in Atlantic Salmon Hepatocytes.

Bou M, Østbye TK, Berge GM, Ruyter B.

Lipids. 2017 Mar;52(3):265-283. doi: 10.1007/s11745-017-4234-5. Epub 2017 Jan 28.

PMID:
28132119
6.

Biceps Disorder Rehabilitation for the Athlete: A Continuum of Moderate- to High-Load Exercises.

Borms D, Ackerman I, Smets P, Van den Berge G, Cools AM.

Am J Sports Med. 2017 Mar;45(3):642-650. doi: 10.1177/0363546516674190. Epub 2016 Dec 14.

PMID:
28125910
7.

Requirements of n-3 very long-chain PUFA in Atlantic salmon (Salmo salar L): effects of different dietary levels of EPA and DHA on fish performance and tissue composition and integrity.

Bou M, Berge GM, Baeverfjord G, Sigholt T, Østbye TK, Romarheim OH, Hatlen B, Leeuwis R, Venegas C, Ruyter B.

Br J Nutr. 2017 Jan;117(1):30-47. doi: 10.1017/S0007114516004396. Epub 2017 Jan 23.

PMID:
28112067
8.

Regulation of the Omega-3 Fatty Acid Biosynthetic Pathway in Atlantic Salmon Hepatocytes.

Kjær MA, Ruyter B, Berge GM, Sun Y, Østbye TK.

PLoS One. 2016 Dec 14;11(12):e0168230. doi: 10.1371/journal.pone.0168230. eCollection 2016.

9.

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.

Berge G, Sando SB, Albrektsen G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, White LR.

BMC Neurol. 2016 Sep 21;16(1):180.

10.

The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release.

Neasta J, Valmalle C, Coyne AC, Carnazzi E, Subra G, Galleyrand JC, Gagne D, M'Kadmi C, Bernad N, Bergé G, Cantel S, Marin P, Marie J, Banères JL, Kemel ML, Daugé V, Puget K, Martinez J.

Br J Pharmacol. 2016 Apr;173(8):1314-28. doi: 10.1111/bph.13424. Epub 2016 Mar 8.

11.

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.

Lauridsen C, Sando SB, Shabnam A, Møller I, Berge G, Grøntvedt GR, Bakken IJ, Salvesen Ø, Bråthen G, White LR.

Front Aging Neurosci. 2016 Mar 1;8:30. doi: 10.3389/fnagi.2016.00030. eCollection 2016.

12.

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.

Vijayaraghavan S, Darreh-Shori T, Rongve A, Berge G, Sando SB, White LR, Auestad BH, Witoelar A, Andreassen OA, Ulstein ID, Aarsland D.

J Alzheimers Dis. 2016;50(2):567-76. doi: 10.3233/JAD-150750.

PMID:
26757188
13.

Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.

Berge G, Lauridsen C, Sando SB, Holder DJ, Møller I, Aasly JO, Bråthen G, Savage MJ, White LR.

J Alzheimers Dis. 2016;49(2):493-502. doi: 10.3233/JAD-150234.

PMID:
26484901
14.

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.

Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM.

Cancer Immunol Immunother. 2015 Jun;64(6):769-76. doi: 10.1007/s00262-015-1686-4. Epub 2015 Apr 2.

PMID:
25832001
15.

Soya Saponins Induce Enteritis in Atlantic Salmon (Salmo salar L.).

Krogdahl Å, Gajardo K, Kortner TM, Penn M, Gu M, Berge GM, Bakke AM.

J Agric Food Chem. 2015 Apr 22;63(15):3887-902. doi: 10.1021/jf506242t. Epub 2015 Apr 10.

PMID:
25798699
16.

Human health risk associated with brominated flame-retardants (BFRs).

Lyche JL, Rosseland C, Berge G, Polder A.

Environ Int. 2015 Jan;74:170-80. doi: 10.1016/j.envint.2014.09.006. Epub 2014 Oct 29. Review.

PMID:
25454234
17.

[G.E. Berge replies].

Berge GE.

Tidsskr Nor Laegeforen. 2014 Aug 19;134(15):1448. doi: 10.4045/tidsskr.14.0913. eCollection 2014 Aug 19. Norwegian. No abstract available.

18.

[The animal welfare act should be expanded to include children].

Berge GE.

Tidsskr Nor Laegeforen. 2014 May 27;134(10):1029. doi: 10.4045/tidsskr.14.0473. eCollection 2014 May 27. Norwegian. No abstract available.

19.

Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.

Camilio KA, Berge G, Ravuri CS, Rekdal O, Sveinbjørnsson B.

Cancer Immunol Immunother. 2014 Jun;63(6):601-13. doi: 10.1007/s00262-014-1540-0. Epub 2014 Mar 28.

20.

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.

Berge G, Sando SB, Rongve A, Aarsland D, White LR.

J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1227-31. doi: 10.1136/jnnp-2013-307228. Epub 2014 Mar 17.

21.

Osteopontin is a prognostic biomarker in non-small cell lung cancer.

Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM.

BMC Cancer. 2013 Nov 11;13:540. doi: 10.1186/1471-2407-13-540.

22.

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.

Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K.

BMC Cancer. 2012 Aug 1;12:333.

23.

Medium-chain and long-chain fatty acids have different postabsorptive fates in Atlantic salmon.

Denstadli V, Bakke AM, Berge GM, Krogdahl A, Hillestad M, Holm H, Ruyter B.

J Nutr. 2011 Sep;141(9):1618-28. doi: 10.3945/jn.111.141820. Epub 2011 Jul 13.

PMID:
21753060
24.

Comment on the Importance of S100A4 in regulation of MMP-13.

Berge G, Andersen K, Haugen MH, Maelandsmo GM.

J Biol Chem. 2010 Dec 31;285(53):le23; author reply le24. doi: 10.1074/jbc.L110.125898. No abstract available.

25.

Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.

Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM.

Int J Cancer. 2011 Aug 15;129(4):780-90. doi: 10.1002/ijc.25735. Epub 2011 Mar 11.

26.

Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a.

Gozé C, Bergé G, M'Kadmi C, Floquet N, Gagne D, Galleyrand JC, Fehrentz JA, Martinez J.

Eur J Pharmacol. 2010 Sep 25;643(2-3):153-61. doi: 10.1016/j.ejphar.2010.06.018. Epub 2010 Jun 30.

PMID:
20599926
27.

Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide.

Berge G, Eliassen LT, Camilio KA, Bartnes K, Sveinbjørnsson B, Rekdal O.

Cancer Immunol Immunother. 2010 Aug;59(8):1285-94. doi: 10.1007/s00262-010-0857-6. Epub 2010 Apr 27.

PMID:
20422410
28.

Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.

Berge G, Costea DE, Berg M, Rasmussen H, Grotterød I, Lothe RA, Mælandsmo GM, Flatmark K.

Amino Acids. 2011 Oct;41(4):875-84. doi: 10.1007/s00726-010-0514-6. Epub 2010 Feb 27.

PMID:
20191297
29.

Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.

Berge G, Mælandsmo GM.

Amino Acids. 2011 Oct;41(4):863-73. doi: 10.1007/s00726-010-0497-3. Epub 2010 Feb 24. Review.

PMID:
20177948
30.

Atlantic salmon (Salmo salar) muscle precursor cells differentiate into osteoblasts in vitro: polyunsaturated fatty acids and hyperthermia influence gene expression and differentiation.

Ytteborg E, Vegusdal A, Witten PE, Berge GM, Takle H, Østbye TK, Ruyter B.

Biochim Biophys Acta. 2010 Feb;1801(2):127-37. doi: 10.1016/j.bbalip.2009.10.001. Epub 2009 Oct 13.

PMID:
19833228
31.

Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).

Floquet N, M'Kadmi C, Perahia D, Gagne D, Bergé G, Marie J, Banères JL, Galleyrand JC, Fehrentz JA, Martinez J.

J Mol Biol. 2010 Jan 29;395(4):769-84. doi: 10.1016/j.jmb.2009.09.051. Epub 2009 Sep 25.

PMID:
19782690
32.

Solid-phase synthesis of dipeptidic and pseudo-dipeptidic potential NOS inhibitors through a side-chain anchoring approach.

Touati-Jallabe Y, Hamzé A, Bergé G, Verna C, Lajoix AD, Fulcrand P, Martinez J, Hernandez JF.

Adv Exp Med Biol. 2009;611:133-4. No abstract available.

PMID:
19400126
33.

Design, synthesis, and biological evaluation of 1,5-benzothiazepine-4-one derivatives targeting factor VIIa/tissue factor.

Ayral E, Gloanec P, Bergé G, de Nanteuil G, Mennecier P, Rupin A, Verbeuren TJ, Fulcrand P, Martinez J, Hernandez JF.

Bioorg Med Chem Lett. 2009 Mar 1;19(5):1386-91. doi: 10.1016/j.bmcl.2009.01.039. Epub 2009 Jan 19.

PMID:
19181521
34.

New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.

Moulin A, Demange L, Ryan J, Mousseaux D, Sanchez P, Bergé G, Gagne D, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2008 Feb 14;51(3):689-93. doi: 10.1021/jm701292s. Epub 2008 Jan 15.

PMID:
18193826
35.

Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.

Moulin A, Demange L, Bergé G, Gagne D, Ryan J, Mousseaux D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2007 Nov 15;50(23):5790-806. Epub 2007 Oct 10.

PMID:
17927165
36.

Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.

Demange L, Boeglin D, Moulin A, Mousseaux D, Ryan J, Bergé G, Gagne D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2007 Apr 19;50(8):1939-57. Epub 2007 Mar 22.

PMID:
17375904
37.

On-line synthesis of pseudopeptide library incorporating a benzodiazepinone turn mimic: biological evaluation on MC1 receptors.

Verdié P, Subra G, Feliu L, Sanchez P, Bergé G, Garcin G, Martinez J.

J Comb Chem. 2007 Mar-Apr;9(2):254-62.

PMID:
17348731
38.

The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.

Eliassen LT, Berge G, Leknessund A, Wikman M, Lindin I, Løkke C, Ponthan F, Johnsen JI, Sveinbjørnsson B, Kogner P, Flaegstad T, Rekdal Ø.

Int J Cancer. 2006 Aug 1;119(3):493-500.

39.

Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.

Mollerup S, Berge G, Baera R, Skaug V, Hewer A, Phillips DH, Stangeland L, Haugen A.

Int J Cancer. 2006 Aug 15;119(4):741-4.

40.

Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.

Morel C, Ibarz G, Oiry C, Carnazzi E, Bergé G, Gagne D, Galleyrand JC, Martinez J.

J Biol Chem. 2005 Jun 3;280(22):21384-93. Epub 2005 Mar 16.

41.

Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene.

Berge G, Øvrebø S, Eilertsen E, Haugen A, Mollerup S.

Br J Cancer. 2004 Oct 4;91(7):1380-3.

42.

Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung.

Berge G, Mollerup S, ØVrebø S, Hewer A, Phillips DH, Eilertsen E, Haugen A.

Lung Cancer. 2004 Sep;45(3):289-97.

PMID:
15301869
43.

Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells.

Berge G, Øvrebø S, Botnen IV, Hewer A, Phillips DH, Haugen A, Mollerup S.

Br J Cancer. 2004 Jul 19;91(2):333-8.

44.

Influence of zinc bacitracin and Bacillus licheniformis on microbial intestinal functions in weaned piglets.

Collinder E, Cardona ME, Berge GN, Norin E, Stern S, Midtvedt T.

Vet Res Commun. 2003 Oct;27(7):513-26.

PMID:
14609263
46.

Evidence for a direct antitumor mechanism of action of bovine lactoferricin.

Eliassen LT, Berge G, Sveinbjørnsson B, Svendsen JS, Vorland LH, Rekdal Ø.

Anticancer Res. 2002 Sep-Oct;22(5):2703-10.

PMID:
12529985
47.

Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.

Mollerup S, Jørgensen K, Berge G, Haugen A.

Lung Cancer. 2002 Aug;37(2):153-9.

PMID:
12140138
48.

Plasma ascorbic acid concentrations in healthy dogs.

Wang S, Berge GE, Sund RB.

Res Vet Sci. 2001 Aug;71(1):33-5.

PMID:
11666145
49.

Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.

Wang S, Berge GE, Hoem NO, Sund RB.

Res Vet Sci. 2001 Aug;71(1):27-32.

PMID:
11666144
50.

Supplemental Content

Support Center